Results 111 to 120 of about 32,295 (302)
Electroconvulsive therapy for treatment-resistant schizophrenia [PDF]
This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to assess the effects (benefits and harms) of ECT for people with treatment-resistant schizophrenia.
Adams, Clive E., Sinclair, Diarmid J. M.
core +1 more source
Regional and local divergence in welfare provision in England and Wales, 1776–1815
Abstract This article uses the township‐level data on welfare expenditure and provision gathered by parish officers in England and Wales at three points between 1776 and 1815 to illuminate regional and local differences during the period. These data have been linked to geographic information system (GIS) mapping systems, facilitating the mapping of ...
John Broad
wiley +1 more source
Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia [PDF]
The prevalence of treatment-resistant schizophrenia points to a discrete illness subtype, but to date its pathophysiologic characteristics are undetermined. Information transfer from ventral to dorsal striatum depends on both striato-cortico-striatal and
Shergill, Sukhwinder S +11 more
core +1 more source
Pyridoxal 5′‐phosphate (PLP) homeostasis relies on salvage enzymes, yet key metabolic branches remain undefined. We identify AKR1C isozymes as previously undescribed contributors that convert pyridoxal into pyridoxine or 4‐pyridoxolactone through reductase and dehydrogenase activities.
Nayu Kito +8 more
wiley +1 more source
Negative symptoms in treatment-resistant schizophrenia and its relationship with functioning [PDF]
Background Recent operational criteria for treatment-resistant schizophrenia (TRS) recognized positive and negative symptoms. TRS patients may have heterogeneity in negative symptoms, but empirical data were lacking. We aimed to characterize TRS patients
Leung, PBM +11 more
core +2 more sources
AIM: The aim of the study was to study the efficacy of modified electroconvulsive therapy (MECT) as an augmentation agent in schizophrenia, with particular emphasis in treatment-resistant schizophrenia.
Chitrakshee Singh +3 more
doaj +1 more source
A Patient with Resistant Schizophrenia [PDF]
John Gunn +4 more
openaire +2 more sources
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
John Lally,1–3 Fiona Gaughran,1,3 Philip Timms,4,5 Sarah R Curran5–7 1Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2Department of Psychiatry, Royal College of ...
Timms P, Lally J, Gaughran F, Curran SR
core
The impact of beliefs about mental health problems and coping on outcome in schizophrenia. [PDF]
Background. Using the theoretical framework of the Self Regulation Model (SRM), many studies have demonstrated that beliefs individuals hold about their physical health problems are important in predicting health outcomes.
Jones, Steven H. +4 more
core +1 more source
Holistic approach to substance‐induced psychosis
Addiction, EarlyView.
Julia M. Lappin +2 more
wiley +1 more source

